Current Medical Research and Opinion
Volume 34, 2018 - Issue 9
Oncology
Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims
Derek WeyckerPolicy Analysis Inc. (PAI), Brookline, MA, USA; Correspondence[email protected]
http://orcid.org/0000-0002-5405-2215
http://orcid.org/0000-0002-5405-2215, , Alexander LonshteynPolicy Analysis Inc. (PAI), Brookline, MA, USA; http://orcid.org/0000-0003-0203-2762
http://orcid.org/0000-0003-0203-2762, , Mark BensinkAmgen Inc., Thousand Oaks, CA, USAhttp://orcid.org/0000-0002-5940-7898
http://orcid.org/0000-0002-5940-7898, & David ChandlerAmgen Inc., Thousand Oaks, CA, USAhttp://orcid.org/0000-0002-1949-7438
http://orcid.org/0000-0002-1949-7438 show all